Entity

Time filter

Source Type

Emeryville, CA, United States

Bionovo was an American biotechnology company focused on the discovery and development of botanically derived treatments for women's health and cancer based in Emeryville, California. The company had two drug candidates in U.S. Food and Drug Administration clinical trials- Menerba a selective estrogen receptor beta agonist for hot flashes associated with menopause and Bezielle for advanced breast cancer. The company has ceased activity and its stock, although still listed, not moved from 0,00 USD since the end of 2012. No statement has been made by the management, nor any indication has been given that the company is still active. The last press statement was about the sell of all the technical equipment and lay off of 90% of the staff. In short words, the company is as good as bankrupted and shut down, although the management never officially admitted it. Wikipedia.


Selective apoptotic extracts of


An extract of


Patent
Bionovo | Date: 2010-09-02

Extracts of various species of the Moraceae family have estrogenic properties. For example, aqueous and ethanolic extracts of


Patent
Bionovo | Date: 2010-02-25

Isolated compounds and combinations of isolated compounds isolated from

Discover hidden collaborations